KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Gains from Sales and Divestitures (2019 - 2025)

Historic Gains from Sales and Divestitures for Cerence (CRNC) over the last 7 years, with Q1 2025 value amounting to $1.3 million.

  • Cerence's Gains from Sales and Divestitures rose 275.31% to $1.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.3 million, marking a year-over-year increase of 275.31%. This contributed to the annual value of $1.3 billion for FY2024, which is 13759074.45% up from last year.
  • Cerence's Gains from Sales and Divestitures amounted to $1.3 million in Q1 2025, which was up 275.31% from $1.1 million recorded in Q4 2024.
  • In the past 5 years, Cerence's Gains from Sales and Divestitures registered a high of $1.3 billion during Q3 2024, and its lowest value of $643678.0 during Q4 2022.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $1.3 million (2024), whereas its average is $79.4 million.
  • As far as peak fluctuations go, Cerence's Gains from Sales and Divestitures plummeted by 4976.53% in 2022, and later soared by 13759074.45% in 2024.
  • Cerence's Gains from Sales and Divestitures (Quarter) stood at $1.3 million in 2021, then tumbled by 49.77% to $643678.0 in 2022, then rose by 26.58% to $814774.0 in 2023, then soared by 30.89% to $1.1 million in 2024, then grew by 24.89% to $1.3 million in 2025.
  • Its Gains from Sales and Divestitures stands at $1.3 million for Q1 2025, versus $1.1 million for Q4 2024 and $1.3 billion for Q3 2024.